Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 228

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women*

Open access
Pasquali, Renato, Casimirri, Francesco·1993·Clinical Endocrinology

Abstract

The association of obesity with hyperandrogenism has aroused a great deal of interest in recent years on the part of many researchers.It has been shown that adipose tissue may play a critical role in regulating peripheral pathways of androgens and oestrogens which in turn may be involved in the control of adipocyte growth and function, interacting in this way with the effects of insulin.Moreover, it has been pointed out that obesity is frequently associated with hyperandrogenism in several hyperandrogenic states and particularly in the polycystic ovary syndrome (PCOS).The most exciting discovery has been that hyperinsulinaemia and insulin resistance are significantly correlated with hyperandrogenism in PCOS women and that insulin may be an important factor in the regulation of ovarian steroidogenesis both in uitro and in uivo.These findings have established the basis on which new hypotheses on the pathogenesis of PCOS have been developed, and also the pathophysiological basis which can explain the frequent association between obesity and PCOS and, probably, the mechanisms by which obesity may cause or favour the development of hyperandrogenism and PCOS in susceptible women.This hypothesis has been further supported by the fact that weight loss can significantly improve both hyperandrogenism and hyperinsulinism * In this article the following abbreviations will be used: E2 (oestradiol), El (oestrone), T (testosterone), DHT (dihydrotestosterone), A (androstenedione), DHEA (dehydroepiandrosterone), DHEAS (dehydroepiandrosterone-sulphate), 17-OHP (1 7-hydroxyprogesterone), SHBG (sex hormone-binding globulin), E l S (oestrone sulphate), A-diol (5cr-androstane-3~, 17P-diol), 17KS (daily urine 17-ketosteroids), LH (luteinizing hormone), FSH (follicle-stimulating hormone), GnRH (gonadotrophin releasing hormone), IGF-I (insulin growth factor-I), /I-EP (@-endorphin), PGE2 (prostaglandin E2), 34K IGF-BP (34 kb insulin-growth-factor binding globulin).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.1993.tb01744.x

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 228

Metadata

Authors
Pasquali, R., & Casimirri, F.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
1993-07
Volume
39
Issue
1
Pages
1-16
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2074755164
Cited by
228
References
10
FWCI
8.26
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women*. https://app.cochat.ai/papers/10.1111/j.1365-2265.1993.tb01744.x
The paper
Pasquali, R., & Casimirri, F. (1993). The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women*. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.1993.tb01744.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.